Teresa Barroso, DVM, PhD, obtained her PhD in Health Sciences from University of Minho in 2021, being a Veterinary Doctor since 2005 (University of Porto), and a specialist in Molecular Genetics (2007). Solid academic background and research experience in Artificial Intelligence (AI) applied to Healthcare, developing biosensors based on magnetoresistive and intelligent photonics technologies, chemometrics, and molecular biosensing. Currently, Professor of Veterinary Pharmacology at CESPU and Scientific Researcher at INESC TEC, where her research interests focus on reagent-less AI point-of-care (POC) spectroscopy for one drop of blood analysis in Human Healthcare and Veterinary Medicine. Doctor of Veterinary Medicine (DVM), with experience of 21 years in Scientific Research, and 19 years in Business Development activities. Currently Professor at CESPU – Instituto Universitário de Ciências da Saúde (University Institute of Health Sciences), being responsible (Regent) for the curricular units of Veterinary Pharmacology of the Integrated Master’s Degree in Veterinary Medicine (MIMV). Scientific Researcher at INESC TEC - Institute for Systems and Computer Engineering, Technology and Science, collaborating with the projects PocketVet “Towards On-Site Dairy Cow Mastitis Diagnosis in Your Pocket” and “MyVet - Reagent-less point-of-care for veterinary blood analysis” (veterinary point-of-care diagnostic platform for clinical analysis based on spectroscopy and Artificial Intelligence, using one drop of blood), and the human healthcare studies “Non Invasive Hemogram Analysis: a step towards an optical bracelet wearable device”, “Spectroscopy Human Hemogram Analysis”, “Reagent-less Point-of-Care for Hemogram Analysis in the Emergency Room”; “Blood Serum Clinical Chemistry Through Spectroscopy”, and “Urinalysis Without Reagents”. Solid academic background and professional experience in Veterinary Clinical Pathology: i. Currently Scientific Researcher on veterinary clinical analysis; ii. Creation and implementation of 2 veterinary laboratories during a 10-year period (INNO and IDVet); iii. PhD in Health Sciences on the theme of biosensor for tuberculosis diagnosis. Strong knowledge on Clinical Research, for both Veterinary and Human Medicine (“One Health”), including FELASA Laboratory Animal Science former Category C (Project Coordinator) and Clinical Investigator Certification, respectively. Worked in international and interdisciplinary research environments, where the project in INL - International Iberian Nanotechnology Laboratory can be highlighted. Past positions include CEO and Scientific/Technical Director of 2 Clinical Analysis Veterinary Laboratories, Business Development Manager in a Clinical Research Company and a Nanosciences company. Significant experience in application for funding sources, coordinate R&D projects, and facilitate the channel from lab-to-market. Excellent organization and planning capacities, proactive, strong analytical skills, and critical thinking. Effective problem-solving abilities, accomplishing goals efficiently, according to schedule and working under pressure. Good interpersonal skills, known for planning and managing tasks, but also working in team and independently. Good written/oral communication skills. Multilingual (English, Portuguese, Spanish, French, Italian). Exceptional ability for building and fostering strategic partnerships, both with companies and universities. Accomplished international partnerships: multinational pharmaceutical company Boehringer Ingelheim (2017- 2021: “VetPAT” project), commercial representation contract of the multinational company ENVIGO (2015: experimental animals), and commercial partnership with the multinational company IDEXX (2011: veterinary clinical analysis).